A trial evaluated whether rituximab can attain remission in adults with frequently relapsing nephrotic syndrome (FRNS) or steroid dependent nephrotic syndrome (SDNS).

Nephrotic Syndrome is a chronic kidney disorder characterized by proteinuria, hypoalbuminemia, edema, and hyperlipidemia due to glomerular damage. The global market sees growth from rising chronic ...

Researchers from The University of Osaka have found that rituximab, a monoclonal antibody approved for the treatment of nephrotic syndrome in children in Japan, also improves disease management in ...

Primary nephrotic syndrome in adults, including minimal-change nephrotic syndrome, has an incidence of roughly 0.2 to 0.8 per 100,000 person-years. It is characterized by severe proteinuria and ...

Nephrotic syndrome is characterized by a set of signs and symptoms including proteinuria, low protein levels in the blood, hypercholesterolemia, hypertriglyceridemia, and edema. It may be caused by ...

Use of NSAIDs was associated with a greater risk for nephrotic syndrome after at least 2 weeks of exposure, according to a recently published study. “Several studies demonstrated that conventional ...

ATTENTION has been called to the fact that patients who have lost most of their normal capacity to eliminate water, potassium and phosphate as a consequence of severe renal damage may nonetheless ...

Idiopathic nephrotic syndrome is the most common disorder of glomerular function in pediatrics. [1] Approximately 40% of children diagnosed with idiopathic nephrotic syndrome will have a relapsing ...

One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...

THE nephrotic syndrome and pregnancy rarely co- exist. This may be attributed to the relative infrequency of this disease during the childbearing period and to the obstacles to conception afforded by ...

One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...